Inventor
ULRICH HEINZ
DE14 patents
⚠️ This page may combine multiple inventors who share the name “ULRICH HEINZ”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ASTA MEDICA AG
10 patentsUS5569670AOct 29, 1996
Combination medications containing alpha-lipoic acid and related
ASTA MEDICA AG112 citations96
US5693664ADec 2, 1997
Use of R-(+)-α-lipoic acid, R-(-)dihydrolipoic acid and metabolites in the form of the free acid or salts or esters or amides for the preparation of drugs for the treatment of diabetes mellitus as well as of its sequelae
ASTA MEDICA AG49 citations94
US6117899ASep 12, 2000
Use of R-(+)-α-lipoic acid, R-(-)-dihydrolipoic acid and metabolites in the form of the free acid or as salts or esters or amides for the preparation of drugs for the treatment of diabetes mellitus as well as its sequelae
ASTA MEDICA AG23 citations91
US5948810ASep 7, 1999
Use of R-(+)-α-lipoic acid, R-(-)-dihydrolipoic acid and metabolites in the form of the free acid or as salts or esters or amides for the preparation of drugs for the treatment of diabetes mellitus as well as of its sequelae
ASTA MEDICA AG21 citations91
US5691379ANov 25, 1997
Dihydrolipoic acid as an ophthalmological agent to suppress intolerance reactions in the area between implants and living body tissue
ASTA MEDICA AG75 citations91
US5650429AJul 22, 1997
Use of DL-(+/-)-α-lipoic acid, D-(+)-α-lipoic acid, α-lipoic acid in reduced or oxidized form or salts for treating circulatory disorders
ASTA MEDICA AG35 citations88
US6284787B1Sep 4, 2001
Use of R-(+)-α-lipoic acid, R-(−)-dihydrolipoic acid and metabolites in the form of the free acid or as salts or esters or amides for the preparation of drugs for the treatment of diabetes mellitus as well as of its sequelae
ASTA MEDICA AG13 citations80
US5721258AFeb 24, 1998
Primary and secondary neuroprotective effect of flupirtine in neurodegenerative diseases
ASTA MEDICA AG11 citations73
US5827643AOct 27, 1998
Method of increasing viability of stored erythrocytes by addition of lipoic, dihydrolipoic, 6,8-bisnortetralipoic, or tetranorlipoic acid
ASTA MEDICA AG16 citations69
US6124326ASep 26, 2000
Use of flupirtine for the prophylaxis and therapy of disorders which are associated with an unphysiologically high cell death rate
ASTA MEDICA AG4 citations50
ASTA PHARMA AG
3 patentsUS5728735AMar 17, 1998
Pharmaceutical composition containing R-α-lipoic acid or S-α-lipoic acid as active ingredient
ASTA PHARMA AG73 citations95
US6271254B1Aug 7, 2001
Pharmaceutical compositions containing R-α-lipoic acid or S-α-lipoic acid as active ingredient
ASTA PHARMA AG26 citations92
US5084481AJan 28, 1992
Method of treating inflammatory diseases with pharmaceutical composition containing dihydrolipoic acid as active substance
ASTA PHARMA AG39 citations92